We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 111 for:    Polycystic Kidney Disease

Lanreotide In Polycystic Kidney Disease Study (LIPS)

This study is currently recruiting participants.
Verified August 2016 by Assistance Publique - Hôpitaux de Paris
Sponsor:
ClinicalTrials.gov Identifier:
NCT02127437
First Posted: April 30, 2014
Last Update Posted: August 26, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
IPSEN pharmaceutical company, Boulogne-Billancourt, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2019
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)